Melperone
Systematic (IUPAC) name | |
---|---|
1-(4-fluorophenyl)-4-(4-methylpiperidin-1-yl)butan-1-one
|
|
Clinical data | |
Trade names | Buronil |
AHFS/Drugs.com | International Drug Names |
Legal status |
|
Routes of administration |
Oral, intramuscular injection |
Pharmacokinetic data | |
Bioavailability | 87% (IM), 54% (Oral via syrup), 65% (Oral, tablet)[1] |
Protein binding | 50% |
Metabolism | Hepatic |
Biological half-life | 3–4 hours (oral)[1] 6 hours (IM) |
Excretion | Renal (70% as metabolites, 5.5–10.4% as unchanged drug)[1][2] |
Identifiers | |
CAS Number | 3575-80-2 |
ATC code | N05AD03 (WHO) |
PubChem | CID: 15387 |
ChemSpider | 14646 |
UNII | J8WA3K39B7 |
KEGG | D07309 |
Chemical data | |
Formula | C16H22FNO |
Molecular mass | 263.35 g/mol |
|
|
|
|
(verify) |
Melperone (Bunil (PT), Buronil (AT, BE, CZ, DK, FL†, NL†, NO†, SE), Eunerpan (DE))[3] is an atypical antipsychotic of the butyrophenone chemical class, making it structurally related to the typical antipsychotic haloperidol. It first entered clinical use in 1960s.[4]
Contents
Marketing and indications
It has been tried in treatment-resistant cases of schizophrenia with some (albeit limited) success.[4][5][6][7] It has also been reported effective in the treatment of L-DOPA and other forms of psychosis in Parkinson's disease[8] (although a multicentre, double-blind, placebo-controlled study conducted in 2012 failed to support these findings[9]). It is also known to possess anxiolytic properties.[10] It is marketed in the following countries:[3]
<templatestyles src="Div col/styles.css"/>
Adverse effects
Melperone is reported to produce significantly less weight gain than clozapine and approximately as much weight gain as typical antipsychotics.[11] It is also purported to produce around as much prolactin secretion as clozapine (which is virtually nill).[12] It is also purported to produce sedative effects[13] and QT interval prolongation.[14] It is also known to produce less extrapyramidal side effects than the first-generation (typical) antipsychotic, thiothixene.[15] It can also produce (usually relatively mild) dry mouth.[16]
<templatestyles src="Div col/styles.css"/>
- Constipation
- Diarrhea
- Nausea
- Vomiting
- Appetite loss
- Hypersalivation (drooling)
- Extrapyramidal side effects*
- Insomnia
- Agitation
- Headache
- Dizziness
- Fatigue
- Miosis
- Mydriasis
- Blurred vision
- Elevated liver enzymes (esp. ALT and GGTP)
* tremor, dystonia, hypokinesis, akathisia, dyskinesias
- Tardive dyskinesia
- Neuroleptic malignant syndrome
- Blood dyscrasias (pancytopenia, agranulocytosis, leukopenia, thrombocytopenia, etc.)
<templatestyles src="Div col/styles.css"/>
- Seizures (probably rare/uncommon)
- Increased intraocular pressure
- Intrahepatic cholestasis (probably rare)
- Orthostatic hypotension (probably common)
- Arrhythmias
- Rash
- Hyperprolactinemia**
- Weight gain
- Increased appetite
** which can lead to galactorrhea, gynecomastia, etc.
Interactions
Melperone is reported to be a CYP2D6 inhibitor.[20][21][22]
Pharmacology
Melperone binds to the dopamine D2 receptor, just like all other clinically-utilized antipsychotics, but it does so with a very low affinity and hence may be liable to rapidly dissociate from the D2 receptor hence potentially giving it the profile of an atypical antipsychotic.[23]
Receptor | Ki [nM][24] |
---|---|
5-HT1A | 2,200 |
5-HT1D | 3,400 |
5-HT2A | 230 |
5-HT2C | 2,100 |
5-HT6 | 1,254 |
5-HT7 | 578 |
α1 | 180 |
α2 | 150 |
M1 | >10,000 |
M2 | 2,400 |
M3 | >10,000 |
M4 | 4,400 |
M5 | >10,000 |
D2 | 194 |
D3 | 8.95 |
D4 | 555 |
H1 | 580 |
See also
References
- ↑ 1.0 1.1 1.2 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Product Information: Eunerpan®, Melperonhydrochlorid. Knoll Deutschland GmbH, Ludwigshafen, 1995.
- ↑ 3.0 3.1 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 4.0 4.1 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Barbato L, Monge A, Stocchi F, Nordera G. Melperone in the treatment of iatrogenic psychosis in Parkinson’s disease. Funct Neurol. 1996 Aug;11(4):201–7.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 17.0 17.1 17.2 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 18.0 18.1 18.2 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ 19.0 19.1 19.2 Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
External links
- PubChem Substance
- Clinical trial number NCT00125138 at ClinicalTrials.gov
- Drugs with non-standard legal status
- Chemical articles having calculated molecular weight overwritten
- Infobox drug articles without a structure image
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Pages using div col with unknown parameters
- Atypical antipsychotics
- Organofluorides
- Aromatic ketones
- Piperidines
- Butyrophenone antipsychotics
- Dopamine antagonists
- Serotonin antagonists
- Alpha-1 blockers
- Alpha-2 blockers